Catalyst Wire Dossier Catalyst Wire Dossier

EQU-001

· Equilibre Biopharmaceuticals B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EQU-001, covering 2023-05-15 to 2023-05-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy [Phase 2]

See pricing